A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11-12 months.

Sven Arne Silfverdal,Giancarlo Icardi,Timo Vesikari,Sheryl Flores,Marco F. Pagnoni,Jin Xu,G. Frank Liu,Jon E. Stek,Florence Boisnard,Stéphane Thomas,Eddy Ziani,Andrew W. Lee

Vaccine（2016）

引用 29|浏览32

暂无评分

摘要

Background: Combination vaccines simplify vaccination visits and improve coverage and timeliness. DTaP5-HB-IPV-Hib is a new investigational, fully-liquid, combination vaccine designed to protect ag ...

查看译文

关键词

DTaP,Polio,Hib,Hepatitis B,Hexavalent,Vaccine,Safety,Immunogenicity

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要